ArticleCardiovascular drugs and therapy2017

Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al.

Manisha Gupte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.